Bio-Rad to offer Propel Labs cell sorting system

The S3 is an automated, benchtop sorting flow cytometer

The S3 Cell Sorter allows researchers to conduct cell sorting on their benchtop

BioRad Laboratories, a multinational manufacturer and distributor of life science research and clinical diagnostic products, has acquired a new cell sorting system from Propel Labs.

The Avalon automated, easy-to-use benchtop sorting flow cytometer will be offered by Bio-Rad as the S3 Cell Sorter, with first shipments scheduled for next January.

Owing to their size, complexity, and maintenance, cell sorting instruments have traditionally been found in shared research service facilities. The compact size, ease-of-use, and affordability of the S3 Cell Sorter allows individual researchers to conduct cell sorting on their benchtop.

‘With this acquisition, we benefit from Propel Labs’ years of expertise in cell sorting,’ said Brad Crutchfield, president, Life Science Group at Bio-Rad.

‘The S3 Cell Sorter fits in well with Bio-Rad’s existing product workflow and will offer researchers greater access to targeting specific cells in their experiments and ultimately increasing the sensitivity of their assays.’

Bio-Rad’s S3 Cell Sorter uses established jet-in-air technology and is equipped with one or two lasers and up to four fluorescent detectors as well as forward and side scatter detectors.

The new ProDrop technology automates set-up and calibration in less than 30 minutes, which allows samples to be sorted at high speeds while maintaining sensitivity and high purity.

The completely internalised fluidics and temperature control system enable a compact size to fit in any lab.

Each S3 Cell Sorter is shipped with the ProAnalyzer software package. Installation and on-site training can be completed within three days.

Founded in 1952, Bio-Rad is headquartered in Hercules, CA, US and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs more than 7,100 people globally and had revenues exceeding US$2bn in 2011.

Companies